Bone, skin and soft tissue chronic wounds emanating from burns or bacterial infections which persist due to prolonged tissue inflammation contribute to a delay in wound healing. Electrospun biomimetic scaffolds produced from biodegradable polymers have proven to be a better alternative due to their large surface area to volume ratio and ability to release the drug directly to the wound surface allowing fast and sustained absorbance over the affected wound area. In this study, poly lactic acid (PLA) (20% w/v) and collagen-based (PLA/C) fibrous scaffolds (electrospun at a voltage of 22 kV, flow rate of 0.1 mL/min) containing varying concentrations of silver sulphadiazine (1% w/w, 0.75% w/w) (Ag + S) and Aspalathus linearis (AL) fermented extract (0.025%, 0.1% and 0.5% w/w), were designed and fabricated to increase antimicrobial penetration and cellular biocompatibility. The elastic modulus of samples revealed that incorporating 1% Ag + S and A. linearis extract to PLA solution culminates in a fiber with the superlative stiffness of 2.1.1 GPa. The antimicrobial effect of the scaffolds was evaluated against S. aureus, P. aeruginosa, MRSA and E. coli. PLA/C-Ag + S/AL scaffolds and showed antibacterial activity against both gram +ve and gram −ve bacteria. They were nontoxic to the cells and provided favorable substrates for the neonatal epidermal keratinocytes cells to undergo cell attachment and proliferation. PLA/C-Ag + S/AL scaffolds have a great potential for use in chronic wounds as well as in tissue and bioengineering applications.

Medicinal plant is a major source of drug discovery for disease management. Over 85% of the population in Asia and in the Middle East use herbal medicine for disease management such as SARS caused by coronavirus. Infection from coronavirus is initiated by entry of the virus into a susceptible host cell. The two human coronaviruses of public health importance two decades ago were SARS-CoV and MERS-CoV and now SARS-CoV 2. These three viruses belong to the same class of beta coronavirus and are somewhat similar in genome sequencing, life cycle, mode of entry into a host, mode of transmission and clinical manifestations. This review identified twenty medicinal plants with potential inhibitory bioactive compounds from natural sources that are active against coronaviruses that could be developed into various drug delivery systems. It also highlighted several evidences to show that medicinal plant used in the treatment of SARS-CoV may offer some sort of relief from the burden of COVID 19 pandemic. Since there is no specific treatment for COVID 19 yet, the search for medicinal plants with inhibitory bioactive compounds against coronavirus could be the long awaited breakthrough scientists have been searching to change the narratives of Covid-19 pandemic.

Biomaterials are constructed to promote or stimulate the processes of wound healing. Polymeric biomaterials can be used to hydrate the wound and serve as barrier to pathogens with plant extracts, antimicrobial agents and extracellular components incorporated to stimulate the healing process. The biological and physical augmentation provided by extracellular matrix derived implants continues facilitate innovation in biomaterials utilized in management of nonhealing wounds. Tissue-processing methodologies can birth extracellular matrix-based devices with characteristic post-implantation responses ranging from the classic foreign body encapsulation of a permanent implant, to one where the implant is degraded and resorbed, to one where the processed extracellular matrix implant is populated by local fibroblasts and supporting vasculature to produce, a viable and metabolically active tissue. Extracellular matrix components and plant extracts have been shown to possesses pharmacological properties with potential for use in the treatment of skin diseases and wound healing. Antioxidant, anti-inflammatory assays, and wound healing assays have been shown to support the dermatological and wound healing usage of these medicinal plants extracts.